These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 22221577)

  • 1. Surgical resection for hilar cholangiocarcinoma: experience improves resectability.
    Cannon RM; Brock G; Buell JF
    HPB (Oxford); 2012 Feb; 14(2):142-9. PubMed ID: 22221577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surgical therapy of hilar cholangiocarcinoma].
    Lang H; Kaiser GM; Zöpf T; Sotiropoulos GC; Frilling A; Malagó M; Broelsch CE
    Chirurg; 2006 Apr; 77(4):325-34. PubMed ID: 16568258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
    Yan Y; Lu N; Tian W; Liu T
    Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of hilar resection in the treatment of hilar cholangiocarcinoma.
    Otani K; Chijiiwa K; Kai M; Ohuchida J; Nagano M; Kondo K
    Hepatogastroenterology; 2012 May; 59(115):696-700. PubMed ID: 22469711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant Precise Hemihepatectomy to Improve the Efficacy of Surgical Treatment for Hilar Cholangiocarcinoma: Analysis of 38 Cases.
    Wang L; Geng ZM; Song XG; Zhao YL; Noor H; Shi L; Liu QG
    Hepatogastroenterology; 2014 Jun; 61(132):927-32. PubMed ID: 26158143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
    Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
    Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
    Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
    World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation for hilar cholangiocarcinoma.
    Robles R; Sánchez-Bueno F; Ramírez P; Brusadin R; Parrilla P
    World J Gastroenterol; 2013 Dec; 19(48):9209-15. PubMed ID: 24409049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-operative morbidity results in decreased long-term survival after resection for hilar cholangiocarcinoma.
    Chauhan A; House MG; Pitt HA; Nakeeb A; Howard TJ; Zyromski NJ; Schmidt CM; Ball CG; Lillemoe KD
    HPB (Oxford); 2011 Feb; 13(2):139-47. PubMed ID: 21241432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma.
    Chen KJ; Yang FC; Qin YS; Jin J; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):155-162. PubMed ID: 29636302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
    de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
    Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.
    Sallinen V; Sirén J; Mäkisalo H; Lehtimäki TE; Lantto E; Kokkola A; Nordin A
    Scand J Surg; 2020 Sep; 109(3):219-227. PubMed ID: 30791825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical treatment and prognosis analysis of hilar cholangiocarcinoma].
    Li XC; Li CX; Zhang H; Cheng F; Zhang F; Pu LY; Zhang CY; Wang K; Kong LB; Qian XF; Li DH; Lu WX; Wang P; Yao AH; Bai JF; Wu XF; Chen RX; Wang XH
    Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):290-301. PubMed ID: 38432670
    [No Abstract]   [Full Text] [Related]  

  • 15. Surgical technique and results of intrapancreatic bile duct resection for hilar malignancy (with video).
    Noji T; Okamura K; Tanaka K; Nakanishi Y; Asano T; Nakamura T; Tsuchikawa T; Hirano S
    HPB (Oxford); 2018 Dec; 20(12):1145-1149. PubMed ID: 29941288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor).
    Dinant S; Gerhards MF; Rauws EA; Busch OR; Gouma DJ; van Gulik TM
    Ann Surg Oncol; 2006 Jun; 13(6):872-80. PubMed ID: 16614876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of additional resection of a margin-positive distal bile duct in perihilar cholangiocarcinoma.
    Otsuka S; Ebata T; Yokoyama Y; Mizuno T; Tsukahara T; Shimoyama Y; Ando M; Nagino M
    Br J Surg; 2019 May; 106(6):774-782. PubMed ID: 30889275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.
    Jarnagin WR; Fong Y; DeMatteo RP; Gonen M; Burke EC; Bodniewicz BS J; Youssef BA M; Klimstra D; Blumgart LH
    Ann Surg; 2001 Oct; 234(4):507-17; discussion 517-9. PubMed ID: 11573044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative blood transfusion is not associated with overall survival or time to recurrence after resection of perihilar cholangiocarcinoma.
    Dekker AM; Wiggers JK; Coelen RJ; van Golen RF; Besselink MG; Busch OR; Verheij J; Hollmann MW; van Gulik TM
    HPB (Oxford); 2016 Mar; 18(3):262-70. PubMed ID: 27017166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer.
    Matull WR; Dhar DK; Ayaru L; Sandanayake NS; Chapman MH; Dias A; Bridgewater J; Webster GJ; Bong JJ; Davidson BR; Pereira SP
    Liver Int; 2011 Jan; 31(1):99-107. PubMed ID: 20846273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.